Can you provide an organized overview of total intravenous anesthesia (TIVA), including the ideal characteristics of drugs used for induction, maintenance, and adjuncts, for exam preparation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Total Intravenous Anesthesia (TIVA): Organized Educational Overview

Definition and Core Concept

TIVA is the maintenance of general anesthesia using exclusively intravenous agents—a combination of hypnotic, analgesic, and muscle relaxant drugs—without any inhaled anesthetic agents 1. This technique provides complete anesthesia through continuous or intermittent IV administration, typically using infusion pumps for precise control 2.


Ideal Characteristics of TIVA Drugs

Hypnotic Agents - Essential Properties:

  • Rapid onset and offset allowing smooth induction and quick recovery
  • Predictable dose-plasma-effect relationship for tight control of anesthetic depth 3
  • Rapid elimination from circulation enabling close titration 3
  • Minimal accumulation in peripheral compartments
  • Cardiovascular stability with minimal depression
  • No respiratory irritation (unlike some inhaled agents)
  • Low incidence of postoperative nausea and vomiting (PONV) 4

Analgesic Agents - Essential Properties:

  • Potent analgesia at sub-respiratory depressant doses
  • Rapid onset and offset for intraoperative titration
  • Predictable pharmacokinetics suitable for continuous infusion
  • Minimal hemodynamic effects
  • Context-sensitive half-time allowing timely emergence

Drug Categories and Specific Agents

1. HYPNOTICS (Induction and Maintenance)

Propofol (Gold Standard)

  • Primary choice for TIVA with many characteristics of the ideal IV anesthetic 5
  • Rapid, smooth induction with rapid clearance 5
  • Avoids claustrophobia associated with mask induction 5
  • Reduces PONV incidence 4
  • Dosing: Loading dose followed by continuous infusion to maintain plasma concentrations in hypnotic range 3
  • Caveat: Environmental ecotoxicity for water and soils 6—but this should not override clinical benefit
  • Typical plasma concentrations: 3-4 μg/mL at end of surgery 3

Methohexital (Alternative)

  • Similar pharmacokinetic profile to propofol 3
  • Acceptable alternative when propofol unavailable
  • May cause more restlessness postoperatively 3
  • Longer recovery time (median 50 min vs 25 min for propofol) 3

Ketamine (Adjunct/Alternative)

  • Used in combination regimens, particularly in resource-limited settings 1
  • Provides analgesia and amnesia
  • Maintains cardiovascular stability
  • Useful in hemodynamically unstable patients

Emerging Agents

  • Ciprofol and remimazolam are newer drugs being investigated to potentially upgrade TIVA practice 7

2. ANALGESICS (Maintenance)

Opioids - The Backbone

Alfentanil:

  • Commonly used in TIVA combinations 3
  • Typical dosing: 0.1 mg/kg initial, 0.125 mg/kg/h maintenance 3
  • Stopped 30 minutes before end of surgery 3

Fentanyl:

  • Widely used, well-established profile 1
  • Longer duration than alfentanil
  • Suitable for longer procedures

Sufentanil:

  • More potent than fentanyl
  • Useful for major surgery requiring intense analgesia 1

Remifentanil:

  • Ultra-short acting with context-insensitive half-time
  • Ideal for precise titration
  • Requires transition to longer-acting opioid before emergence

3. MUSCLE RELAXANTS

  • Not specific to TIVA—same agents used as in balanced anesthesia
  • Choice based on duration of surgery, intubating conditions, and reversal needs
  • Examples: rocuronium, vecuronium, atracurium, cisatracurium

Clinical Implementation Algorithm

Step 1: Patient Selection

  • TIVA is appropriate for virtually all patients but particularly beneficial in:
    • Pediatric patients 4
    • Patients at high risk for PONV 4
    • Situations where volatile agents contraindicated
    • Procedures requiring total IV technique (e.g., airway surgery)

Step 2: Equipment Requirements

  • Infusion pumps (preferably target-controlled infusion [TCI] systems) 6
  • Depth of anesthesia monitoring to reduce drug consumption 6, 2
  • Backup IV access
  • Standard monitoring equipment

Step 3: Drug Preparation

  • Prepare medications just before use, not systematically beforehand 6
  • Use pre-filled syringes for occasionally used medicines when available 6
  • Label all syringes clearly

Step 4: Induction Protocol

  • Propofol: Bolus dose (1.5-2.5 mg/kg) OR start infusion with loading scheme
  • Opioid: Bolus (e.g., alfentanil 10-20 μg/kg, fentanyl 1-3 μg/kg)
  • Muscle relaxant: As needed for intubation

Step 5: Maintenance Protocol

  • Two-step infusion approach 3:
    1. Loading phase to fill peripheral compartments
    2. Maintenance phase to sustain therapeutic plasma levels
  • Propofol: Typically 4-12 mg/kg/h (adjust based on depth monitoring)
  • Opioid: Continuous infusion (e.g., alfentanil 0.5-2 μg/kg/min)
  • Monitor depth of anesthesia continuously to optimize drug consumption 6, 2

Step 6: Inadequate Depth Management

If signs of light anesthesia (HR or SBP >25% above baseline) 3:

  1. First: Bolus opioid (e.g., alfentanil 0.5-1 mg)
  2. If ineffective: Bolus hypnotic (e.g., propofol 50 mg)
  3. Increase maintenance infusion rates

Step 7: Emergence Protocol

  • Stop opioid infusion 30 minutes before end of surgery 3
  • Stop hypnotic at skin closure
  • Recovery time varies by agent (propofol ~25 min, methohexital ~50 min) 3

Advantages of TIVA

  • Precise control of anesthetic depth with continuous infusion 5
  • Reduced PONV compared to volatile agents 4
  • Better airway and hemodynamic control 4
  • Avoids volatile agent contraindications (malignant hyperthermia susceptibility)
  • No pollution of operating room environment with anesthetic gases
  • Applicable in field conditions without sophisticated vaporizers 1
  • Reduced greenhouse gas emissions compared to volatile agents (though propofol has water/soil ecotoxicity) 6

Disadvantages and Pitfalls

Common Pitfalls:

  1. Delayed emergence if infusions not stopped appropriately

    • Solution: Stop opioid 30 min before end, stop hypnotic at closure 3
  2. Awareness risk without depth monitoring

    • Solution: Mandatory use of depth of anesthesia monitoring 6, 2
  3. Accumulation with prolonged infusions

    • Solution: Use TCI systems with pharmacokinetic models 6
  4. IV line failure = complete loss of anesthesia

    • Solution: Secure IV access, consider backup line for long cases
  5. Shivering (particularly with methohexital, 56% incidence) 3

    • Solution: Prefer propofol (0% shivering incidence) 3
  6. Hypotension on induction (30-37% drop in systolic BP) 3

    • Solution: Slower induction, adequate preload, vasopressors ready

Environmental Considerations

With equal clinical benefit, anesthesia professionals may choose either TIVA or volatile anesthesia 6. The guideline emphasizes:

  • Volatile agents have greenhouse gas emissions
  • Propofol has ecotoxicity for water and soils
  • Clinical benefit to the patient takes priority over environmental concerns 6
  • When using TIVA, monitor depth to reduce drug consumption 6

Key Guideline Recommendations

From the Association of Anaesthetists and Society for Intravenous Anaesthesia 2:

  • All anaesthetists should be competent in delivering TIVA safely
  • TIVA encompasses pure IV techniques and combinations with inhalational agents
  • Safety protocols must be followed rigorously

From expert consensus 4:

  • Cost, lack of familiarity, and delayed emergence are NOT considered obstacles to TIVA use
  • Primary motivations: patient experience (especially pediatrics) and procedure outcomes
  • PONV reduction and physiological control are priorities

Exam Key Points Summary

Definition: IV hypnotic + IV analgesic + muscle relaxant, NO inhaled agents 1

Ideal drug characteristics: Rapid onset/offset, predictable dose-effect, rapid elimination, minimal accumulation 3

Gold standard combination: Propofol + opioid (alfentanil/fentanyl/remifentanil) 5, 3

Mandatory monitoring: Depth of anesthesia monitoring 6, 2

Timing: Stop opioid 30 min before end, stop hypnotic at closure 3

Main advantages: PONV reduction, precise control, no volatile contraindications 4

Main pitfall: Awareness without monitoring; IV failure = no anesthesia 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.